About 5,910,000 results
After withdrawal, GSK touts another Blenrep combo win as …
GSK announces positive results from DREAMM-8 phase III trial for ...
ASCO 2024 – Blenrep “should return” to the US - ApexOnco
GSK backs up its Blenrep rehab bid with survival data
GSK will pull Blenrep from US market after failed trial
GSK’s Quest to Bring Myeloma Drug Back to the Market ... - MedCity News
FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for …
GSK details Blenrep combo data that could bring the multiple …
GSK provides an update on Blenrep (belantamab mafodotin …
GSK to stop selling blood cancer drug Blenrep in United States